Stories and Innovation in ALS Episode #9:  ALS Reversal #42 with McFinn Lovere @EverythingALS
Stories and Innovation in ALS Episode #9:  ALS Reversal #42 with McFinn Lovere  @EverythingALS
Uploaded September 2021 | Updated September 2026, 3 weeks ago
Episode #9: ALS Reversal #42 with McFinn Lovere (Version 1)

Welcome to Stories and Innovation in ALS.

In this episode, Lisa Deegan interviews her co-host McFinn Lovere, who experienced a rare ALS reversal. His case is documented and is studied as ALS reversal #42 at Duke University.

We will take you through McFinn’s unique journey with ALS, how he recovered, and what his important role as an ALS advocate on the EverythingALS team means to him. McFinn shares details of his role dedicating his time to helping others throughout their ALS journey.

McFinn and Lisa are part of EverythingALS.org, whose mission is to accelerate treatments for ALS through citizen-driven research.

To learn more about EverythingALS, please visit: everythingals.org

Get Involved in ALS Research: everythingals.org/research

SUBSCRIBE to YouTube channel to be connected.
Stories and Innovation in ALS Episode #9:  ALS Reversal #42 with McFinn LovereStories and Innovation in ALS Episode #18:  I can’t Look Away with Allison Bulat.Using induced pluripotent stem cells as a platform for ALS Dr. Nicholas John Maragakis, M.DStories and Innovation in ALS Episode #6:  A Brothers Legacy & A Sister’s Love with Deb FabricatoreWomen at EverythingALSThe ALSTARS Trial: Updates on the COYA 302 Clinical Trial and the Path AheadPrimeC – Connecting the Dots with Alon Ben Noon & Prof. Jeffrey Rosenfeld.Remote Respiratory Monitoring for PALS: Implementation in ALS Multidisciplinary ClinicALS Reversals: An Update for 2022 by Richard BedlackCitizen Research, March 18, 2026Barriers to ALS Therapy Development: Forging a Path Through with Dr. Shafeeq LadhaALS Expert Talk: Preserving nerve-muscle contacts to battle ALS
Everything ALS |

Stories and Innovation in ALS Episode #9: ALS Reversal #42 with McFinn Lovere

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER